Filing Details
- Accession Number:
- 0001104659-21-149797
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-12-15 08:30:01
- Reporting Period:
- 2021-12-10
- Accepted Time:
- 2021-12-15 08:30:01
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1124524 | Cryoport Inc. | CYRX | Pharmaceutical Preparations (2834) | 880313393 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1283212 | Jerrell Shelton | C/O Cryoport Inc. 112 Westwood Place, Suite 350 Brentwood TN 37027 | President, Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-12-10 | 26,418 | $2.40 | 590,510 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2021-12-10 | 38,545 | $3.24 | 629,055 | No | 4 | M | Direct | |
Common Stock | Disposition | 2021-12-10 | 16,427 | $64.94 | 612,628 | No | 4 | S | Direct | |
Common Stock | Disposition | 2021-12-10 | 8,710 | $65.57 | 603,918 | No | 4 | S | Direct | |
Common Stock | Disposition | 2021-12-10 | 1,281 | $66.89 | 602,637 | No | 4 | S | Direct | |
Common Stock | Disposition | 2021-12-10 | 29,144 | $64.89 | 573,493 | No | 4 | S | Direct | |
Common Stock | Disposition | 2021-12-10 | 8,092 | $65.54 | 565,401 | No | 4 | S | Direct | |
Common Stock | Disposition | 2021-12-10 | 1,309 | $66.87 | 564,092 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2021-12-13 | 287 | $3.24 | 564,379 | No | 4 | M | Direct | |
Common Stock | Disposition | 2021-12-13 | 200 | $64.87 | 564,179 | No | 4 | S | Direct | |
Common Stock | Disposition | 2021-12-13 | 87 | $65.84 | 564,092 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Option to purchase common stock | Disposition | 2021-12-10 | 26,418 | $0.00 | 26,418 | $2.40 |
Common Stock | Option to purchase common stock | Disposition | 2021-12-10 | 38,545 | $0.00 | 38,545 | $3.24 |
Common Stock | Option to purchase common stock | Disposition | 2021-12-13 | 287 | $0.00 | 287 | $3.24 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2022-11-05 | No | 4 | M | Direct | |
286,664 | 2023-06-28 | No | 4 | M | Direct | |
286,377 | 2023-06-28 | No | 4 | M | Direct |
Footnotes
- The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 9, 2021.
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.36 to $65.34, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.36 to $66.23, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $66.72 to $67.57, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.36 to $65.35, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.36 to $66.35, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $66.72 to $67.6950, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.55 to $65.18, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- 1/12 of the options vested on the 22nd of each month for twelve months beginning on 11/22/2012 and ending on 10/22/2013.
- 1/6 of the options vested on the 5th of each month for six months beginning on 12/5/2012 and ending on 5/5/2013.
- 1/24 of the options vested immediately and 1/46 of the remaining options vested on the 5th of each month for forty six months beginning on 7/5/2013 and ending on 5/5/2017.